BDX
61
2
FE
53
-2
MOS
26
-3
BEN
49
13
AN
61
9
ZTS
17
-2
MA
48
2
DE
48
5
ROP
50
5
SHW
59
3
AXP
71
2
M
37
-3
IR
63
-5
CRM
52
2
AAL
56
5
ES
40
-2
NOV
58
5
BRK.B
47
-2
HCA
66
-5
PPL
57
-2
BDX
61
2
FE
53
-2
MOS
26
-3
BEN
49
13
AN
61
9
ZTS
17
-2
MA
48
2
DE
48
5
ROP
50
5
SHW
59
3
AXP
71
2
M
37
-3
IR
63
-5
CRM
52
2
AAL
56
5
ES
40
-2
NOV
58
5
BRK.B
47
-2
HCA
66
-5
PPL
57
-2
Financhill
Back

Catalyst Pharmaceuticals, Inc. Stock Predictions

$0.85 Entry Open - Fortune 1000 AI Tech in Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
67

CPRX
Catalyst Pharmaceuticals, Inc.

Last Price:
$23.08
Seasonality Move:
1.44%

7 Day Trial

ALL ACCESS PASS

$ 7

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Catalyst Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 38.4% based on the past 19 years of stock performance.
  • Catalyst Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
  • Is Catalyst Pharmaceuticals, Inc. Stock Undervalued?
    The current Catalyst Pharmaceuticals, Inc. [CPRX] share price is $23.10. The Score for CPRX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Catalyst Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Catalyst Pharmaceuticals, Inc. has on average historically risen by 38.4% based on the past 19 years of stock performance.

Catalyst Pharmaceuticals, Inc. Stock Rating

Buy
67
Catalyst Pharmaceuticals, Inc. (CPRX) is a Buy

Is Catalyst Pharmaceuticals, Inc. overpriced?

  • Catalyst Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%

Catalyst Pharmaceuticals, Inc. Stock Price History

Is CPRX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
catalystpharma.com

52-Week Data

52-Week High:
26.58
52-Week Low:
19.05

Prediction Charts

Market Cap:
2.8B
Price in USD:
23.10
Volume:
1M
Beta:
1.05

Technical Analysis

SMA50:
21.48
SMA100:
21.00
SMA200:
22.06
52-Wk Change:
6.4%

Stock Predictions

  • Is Catalyst Pharmaceuticals, Inc. stock public?
    Yes, Catalyst Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Catalyst Pharmaceuticals, Inc. stock quote today?
    The Catalyst Pharmaceuticals, Inc. stock price is 23.10 USD today.
  • How to buy Catalyst Pharmaceuticals, Inc. stock online?
    You can buy Catalyst Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-13 22.61 23.02 23.28 22.45
Nov-14 22.83 23.18 23.44 22.80
Nov-17 23.22 22.56 23.22 22.40
Nov-18 22.38 22.66 22.73 22.23
Nov-19 22.74 22.51 23.11 22.32
Nov-20 22.69 22.77 22.99 22.48
Nov-21 22.68 23.28 23.62 22.56
Nov-24 23.26 23.51 23.58 23.19
Nov-25 23.67 23.59 23.92 23.53
Nov-26 23.53 23.43 23.72 23.01
Nov-28 23.39 23.41 23.45 23.20
Dec-1 23.14 22.69 23.15 22.64
Dec-2 22.79 22.62 22.93 22.42
Dec-3 22.82 23.10 23.24 22.66

Catalyst Pharmaceuticals, Inc. Earnings

Catalyst Pharmaceuticals, Inc. Earnings Report: Per Share Catalyst Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Catalyst Pharmaceuticals, Inc. Forecast Revenue Growth

Catalyst Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Catalyst Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.08 per share.

* Catalyst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.